SignalChem Biotech
SignalChem Biotech
Unlock Success: Partner with CDMOs for Cell Therapy Manufacturing
BIOT
📅 May 29, 2024: 🧪 Small biotech companies should engage a CDMO early for cell therapy GMP manufacturing. 📝 Documentation, quality control, and trust are key.
Sino Biological Acquires SignalChem Biotech: Boosting Enzyme Expertise and Expanding Protein Presence!
BIOT
📢 Sino Biological acquires SignalChem Biotech for $48 million, boosting their enzyme production and research capabilities. 🔬💰
